======= HOXC11 =======
== Gene Information ==
* **Official Symbol**: HOXC11
* **Official Name**: homeobox C11
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3227|3227]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O43248|O43248]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=HOXC11&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HOXC11|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605559|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Binds to a promoter element of the lactase-phlorizin hydrolase gene.
|Homeobox|
|DUF3528|
|embryonic skeletal joint morphogenesis|
|embryonic skeletal joint development|
|organ induction|
|developmental induction|
|proximal/distal pattern formation|
|regulation of animal organ formation|
|embryonic digit morphogenesis|
|endoderm development|
|positive regulation of animal organ morphogenesis|
|metanephros development|
|embryonic skeletal system morphogenesis|
|embryonic limb morphogenesis|
|embryonic appendage morphogenesis|
|embryonic skeletal system development|
|limb morphogenesis|
|appendage morphogenesis|
|appendage development|
|limb development|
|anterior/posterior pattern specification|
|skeletal system morphogenesis|
|regulation of animal organ morphogenesis|
|kidney development|
|renal system development|
|embryonic organ morphogenesis|
|urogenital system development|
|regionalization|
|embryonic organ development|
|pattern specification process|
|DNA-binding transcription activator activity, RNA polymerase II-specific|
|skeletal system development|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|embryonic morphogenesis|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|animal organ morphogenesis|
|embryo development|
|regulation of anatomical structure morphogenesis|
|positive regulation of transcription by RNA polymerase II|
|positive regulation of developmental process|
|positive regulation of transcription, DNA-templated|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|positive regulation of multicellular organismal process|
|tissue development|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-1.94|
|[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|1.76|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|1/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6029
* **Expression level (log2 read counts)**: -1.76
{{:chemogenomics:nalm6 dist.png?nolink |}}